Ovid Therapeutics Inc

NASDAQ:OVID   10:26:54 AM EDT
1.82
-0.02 (-1.09%)
Earnings Announcements

Ovid Therapeutics Reports First Quarter 2022 Financial Results

Published: 05/10/2022 12:15 GMT
Ovid Therapeutics Inc (OVID) - Ovid Therapeutics Reports First Quarter 2022 Financial Results and Corporate Highlights.
Q1 Loss per Share $0.23.
Q1 Revenue $1.4 Million.
Ovid Therapeutics - Sees Multi-year Cash and Cash Equivalents to Support Progression of Current Pipeline of Differentiated Epilepsy Programs Into 2025.
Q1 Earnings per Share View $-0.21, Revenue View $0.00 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.25

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.25

More details on our Analysts Page.